The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives
Authors:
- 30 April 2008
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 114 (3) , 457-462
Abstract
PALB2 has been recently identified as breast cancer susceptibility gene in western populations. To investigate the contribution of PALB2 mutations to Chinese non-BRCA1/BRCA2 hereditary breast cancer, we screened all coding exons and intron-exon boundaries of PALB2 in 360 Chinese women with early-onset breast cancer or affected relatives from five breast disease clinical centers in China by utilizing PCR-DHPLC and DNA sequencing analysis. Some genetic variants identified in the cases were then studied in 864 normal controls with no personal or family history of breast cancer. Two protein-truncating PALB2 mutations, 751C>T and 1050_1051delAAinsTCT, were identified in three separate families, and 751C>T was a recurrent mutation. Neither of them, however, were present in the controls (P = 0.025). All the truncating mutations occured in exon 4 of PALB2, and there were still three unclassified variants were detected in the same fragment. We found that exon 4 accounted for 44.1% (15/34) of the person-times carrying with any variant in our study. PALB2 mutations were responsible for approximately 1% of Chinese women with early-onset breast cancer and affected relatives. Our results suggested that a detection of exon 4 before the assay of the whole PALB2 gene might be a cost-effective approach to the screening of Chinese population.Keywords
This publication has 17 references indexed in Scilit:
- Identification of a novel truncating PALB2mutation and analysis of its contribution to early-onset breast cancer in French-Canadian womenBreast Cancer Research, 2007
- The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identifiedBreast Cancer Research and Treatment, 2007
- Fanconi Anemia: Fanconi anemia, breast and embryonal cancer risk revisitedEuropean Journal of Human Genetics, 2007
- Analysis ofPALB2/FANCN-associated breast cancer familiesProceedings of the National Academy of Sciences, 2007
- A recurrent mutation in PALB2 in Finnish cancer familiesNature, 2007
- PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility geneNature Genetics, 2006
- Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancerNature Genetics, 2006
- BRCA Mutation Frequency and Penetrance: New Data, Old DebateJNCI: Journal of the National Cancer Institute, 2006
- Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2Molecular Cell, 2006
- The analysis ofBRCA1 mutations in eastern Chinese patients with early onset breast cancer and affected relativesHuman Mutation, 2003